GRAIL to Showcase Innovations in Early Cancer Detection at J.P. Morgan Conference#USA#San_Francisco#GRAIL#cancer_detection#Nasdaq_GRAL
GRAIL to Showcase Innovations in Early Cancer Detection at J.P. Morgan Conference
GRAIL, Inc. will present at the 44th J.P. Morgan Healthcare Conference, sharing groundbreaking approaches to cancer detection and management.
third-news.com
December 15, 2025 at 9:15 PM
GRAIL to Showcase Innovations in Early Cancer Detection at J.P. Morgan Conference#USA#San_Francisco#GRAIL#cancer_detection#Nasdaq_GRAL
Yenos Analytical Unveils Revolutionary Urine Test for Early Cancer Detection#United_States#cancer_detection#El_Dorado_Hills#Yenos_Analytical#MCED_Test
Yenos Analytical Unveils Revolutionary Urine Test for Early Cancer Detection
Discover Yenos Analytical's groundbreaking urine test for early detection of multiple cancers, promising 97% accuracy. It's a game-changer in cancer diagnostics!
third-news.com
December 9, 2025 at 2:42 PM
Yenos Analytical Unveils Revolutionary Urine Test for Early Cancer Detection#United_States#cancer_detection#El_Dorado_Hills#Yenos_Analytical#MCED_Test
GC Genome's Study Uncovers Key Confounders Affecting Cancer Signal Detection in Liquid Biopsy#South_Korea#Liquid_Biopsy#Yongin#cancer_detection#GC_Genome
GC Genome's Study Uncovers Key Confounders Affecting Cancer Signal Detection in Liquid Biopsy
A new study by GC Genome reveals critical physiological factors influencing cfDNA signals, paving the way to enhance liquid biopsy accuracy.
third-news.com
December 9, 2025 at 7:07 AM
GC Genome's Study Uncovers Key Confounders Affecting Cancer Signal Detection in Liquid Biopsy#South_Korea#Liquid_Biopsy#Yongin#cancer_detection#GC_Genome
Astrin Biosciences Unveils New Advisory Board to Enhance Early Cancer Detection with AI Innovations#United_States#AI_Technology#cancer_detection#St._Paul#Astrin_Biosciences
Astrin Biosciences Unveils New Advisory Board to Enhance Early Cancer Detection with AI Innovations
Astrin Biosciences has formed a Scientific Advisory Board with leading experts to expedite advancements in early cancer detection using AI and proteomics, aiming for routine Stage 0 identification.
third-news.com
December 8, 2025 at 1:25 PM
Astrin Biosciences Unveils New Advisory Board to Enhance Early Cancer Detection with AI Innovations#United_States#AI_Technology#cancer_detection#St._Paul#Astrin_Biosciences
Freenome and Perceptive Capital Solutions to Revolutionize Multi-Cancer Detection via AI/ML Platform#United_States#New_York#Freenome#Multi-Cancer_Detection#AI/ML_Platform
Freenome and Perceptive Capital Solutions to Revolutionize Multi-Cancer Detection via AI/ML Platform
Freenome and Perceptive Capital Solutions have launched a transformative business agreement aimed at enhancing early cancer detection utilizing an advanced AI/ML multiomics platform.
third-news.com
December 5, 2025 at 1:40 PM
Freenome and Perceptive Capital Solutions to Revolutionize Multi-Cancer Detection via AI/ML Platform#United_States#New_York#Freenome#Multi-Cancer_Detection#AI/ML_Platform
GRAIL, Inc. Unveils New Inducement Grants for Non-Executive Employees#United_States#Inc.#Menlo_Park#RSUs#GRAIL#cancer_detection
GRAIL, Inc. Unveils New Inducement Grants for Non-Executive Employees
GRAIL, Inc. has announced the granting of equity awards to recently hired non-executive employees under NASDAQ rules, aimed at early cancer detection.
third-news.com
December 1, 2025 at 9:08 PM
GRAIL, Inc. Unveils New Inducement Grants for Non-Executive Employees#United_States#Inc.#Menlo_Park#RSUs#GRAIL#cancer_detection
Peter Gilgan Donates $50 Million for Revolutionary Cancer Detection Program#Canada#Toronto#cancer_detection#Peter_Gilgan#Princess_Margaret
Peter Gilgan Donates $50 Million for Revolutionary Cancer Detection Program
Peter Gilgan has made a groundbreaking donation of $50 million to establish the world's largest early cancer detection research program at Princess Margaret Cancer Centre.
third-news.com
November 26, 2025 at 2:54 PM
Peter Gilgan Donates $50 Million for Revolutionary Cancer Detection Program#Canada#Toronto#cancer_detection#Peter_Gilgan#Princess_Margaret
Development of Compact Sensor for Rapid Detection of Cancer Markers for Home Medical Monitoring#Japan#Tokyo#cancer_detection#Home_Healthcare#HSP90
Development of Compact Sensor for Rapid Detection of Cancer Markers for Home Medical Monitoring
A new compact sensor that quickly detects cancer markers like HSP90 is paving the way for early cancer detection and monitoring in home healthcare settings.
third-news.com
November 20, 2025 at 5:52 AM
Development of Compact Sensor for Rapid Detection of Cancer Markers for Home Medical Monitoring#Japan#Tokyo#cancer_detection#Home_Healthcare#HSP90
Dan Collins Joins TOBY as Advisor to Guide Cancer Detection Innovations#USA#Boston#cancer_detection#TOBY_Inc.#Dan_Collins
Dan Collins Joins TOBY as Advisor to Guide Cancer Detection Innovations
TOBY, Inc. welcomes Dan Collins as an advisor to its Board to enhance cancer detection solutions with his international experience and expertise.
third-news.com
November 13, 2025 at 5:27 PM
Dan Collins Joins TOBY as Advisor to Guide Cancer Detection Innovations#USA#Boston#cancer_detection#TOBY_Inc.#Dan_Collins
GRAIL Reports Impressive Third Quarter Financial Results, Galleri Sees Significant Growth#USA#Menlo_Park#GRAIL#cancer_detection#Galleri
GRAIL Reports Impressive Third Quarter Financial Results, Galleri Sees Significant Growth
GRAIL, Inc. shares exciting financial updates for Q3 2025, showcasing significant growth in Galleri test sales and strategic collaborations aimed at expanding market reach.
third-news.com
November 12, 2025 at 9:12 PM
GRAIL Reports Impressive Third Quarter Financial Results, Galleri Sees Significant Growth#USA#Menlo_Park#GRAIL#cancer_detection#Galleri
Lunit Unifies Under One Brand, Transforming AI Cancer Detection and Care#AI#South_Korea#Seoul#Lunit#cancer_detection
Lunit Unifies Under One Brand, Transforming AI Cancer Detection and Care
Lunit has rebranded Volpara Health Technologies, unifying its efforts in AI for cancer detection and treatment under a single identity to enhance patient care.
third-news.com
November 7, 2025 at 12:23 AM
Lunit Unifies Under One Brand, Transforming AI Cancer Detection and Care#AI#South_Korea#Seoul#Lunit#cancer_detection
GRAIL to Showcase Innovations in Early Cancer Detection at Wolfe Research Conference#United_States#Menlo_Park#Healthcare_Innovation#GRAIL#cancer_detection
GRAIL to Showcase Innovations in Early Cancer Detection at Wolfe Research Conference
GRAIL, Inc. is set to present its groundbreaking work in early cancer detection at the Wolfe Research Healthcare Conference, highlighting innovative technologies.
third-news.com
November 4, 2025 at 9:27 PM
GRAIL to Showcase Innovations in Early Cancer Detection at Wolfe Research Conference#United_States#Menlo_Park#Healthcare_Innovation#GRAIL#cancer_detection
GRAIL, Inc. Secures $325 Million in Private Placement Financing to Advance Cancer Detection Technology#United_States#Menlo_Park#GRAIL#cancer_detection#Private_Placement
GRAIL, Inc. Secures $325 Million in Private Placement Financing to Advance Cancer Detection Technology
GRAIL, Inc. announces a private placement financing of $325 million aimed at enhancing its cancer detection capabilities and operational funding.
third-news.com
October 20, 2025 at 10:37 AM
GRAIL, Inc. Secures $325 Million in Private Placement Financing to Advance Cancer Detection Technology#United_States#Menlo_Park#GRAIL#cancer_detection#Private_Placement
GRAIL PATHFINDER 2 Study Confirms Galleri Test Revolutionizes Cancer Detection with Remarkable Success#USA#Menlo_Park#GRAIL#cancer_detection#Galleri
GRAIL PATHFINDER 2 Study Confirms Galleri Test Revolutionizes Cancer Detection with Remarkable Success
GRAIL's PATHFINDER 2 study highlights the Galleri multi-cancer detection test's over seven-fold increase in cancer detection rates when combined with standard screenings. This innovation offers hope in early-stage cancer identification.
third-news.com
October 17, 2025 at 10:11 PM
GRAIL PATHFINDER 2 Study Confirms Galleri Test Revolutionizes Cancer Detection with Remarkable Success#USA#Menlo_Park#GRAIL#cancer_detection#Galleri
bioAffinity Technologies Secures $1.8 Million Financing Through WallachBeth Capital#United_States#Jersey_City#cancer_detection#WallachBeth_Capital#bioAffinity_Technologies
bioAffinity Technologies Secures $1.8 Million Financing Through WallachBeth Capital
bioAffinity Technologies announces a $1.8 million financing deal led by WallachBeth Capital, focusing on its noninvasive lung cancer test.
third-news.com
October 8, 2025 at 8:29 PM
bioAffinity Technologies Secures $1.8 Million Financing Through WallachBeth Capital#United_States#Jersey_City#cancer_detection#WallachBeth_Capital#bioAffinity_Technologies
GRAIL Sets to Reveal Galleri® Insights From 32,000 Participants at ESMO Congress 2025#USA#Menlo_Park#GRAIL#cancer_detection#Galleri
GRAIL Sets to Reveal Galleri® Insights From 32,000 Participants at ESMO Congress 2025
At the ESMO Congress 2025, GRAIL will present significant new findings on the Galleri® test's effectiveness from extensive clinical studies, helping to redefine early cancer detection.
third-news.com
September 23, 2025 at 1:39 PM
GRAIL Sets to Reveal Galleri® Insights From 32,000 Participants at ESMO Congress 2025#USA#Menlo_Park#GRAIL#cancer_detection#Galleri
Lucid Diagnostics Completes Public Offering, Boosting Cancer Detection Efforts#United_States#New_York#Lucid_Diagnostics#cancer_detection#Public_Offering
Lucid Diagnostics Completes Public Offering, Boosting Cancer Detection Efforts
Lucid Diagnostics Inc. has successfully concluded its public offering of common stock, raising crucial funds for cancer prevention initiatives. Learn more!
third-news.com
September 11, 2025 at 1:49 PM
Lucid Diagnostics Completes Public Offering, Boosting Cancer Detection Efforts#United_States#New_York#Lucid_Diagnostics#cancer_detection#Public_Offering
GRAIL Announces Key Presentation at Bernstein Healthcare Forum to Spotlight Cancer Detection Innovations#USA#healthcare#Menlo_Park#GRAIL#cancer_detection
GRAIL Announces Key Presentation at Bernstein Healthcare Forum to Spotlight Cancer Detection Innovations
GRAIL, Inc. will showcase its groundbreaking cancer detection technologies at the 2nd Annual Bernstein Healthcare Forum, emphasizing early detection's role in treatment.
third-news.com
September 10, 2025 at 8:11 PM
GRAIL Announces Key Presentation at Bernstein Healthcare Forum to Spotlight Cancer Detection Innovations#USA#healthcare#Menlo_Park#GRAIL#cancer_detection
Cizzle Bio CEO Bill Behnke Honored as Most Inspiring Business Leader 2025 by CXO Outlook#United_States#San_Antonio#cancer_detection#Cizzle_Bio#Bill_Behnke
Cizzle Bio CEO Bill Behnke Honored as Most Inspiring Business Leader 2025 by CXO Outlook
Bill Behnke, CEO of Cizzle Bio, has been recognized as the Most Inspiring Business Leader 2025 by CXO Outlook for his innovations in cancer detection.
third-news.com
September 3, 2025 at 1:57 PM
Cizzle Bio CEO Bill Behnke Honored as Most Inspiring Business Leader 2025 by CXO Outlook#United_States#San_Antonio#cancer_detection#Cizzle_Bio#Bill_Behnke
Mercy BioAnalytics Secures $59 Million in Funding for Cancer Detection Initiatives#United_States#Waltham#cancer_detection#Ovarian_Cancer#Mercy_BioAnalytics
Mercy BioAnalytics Secures $59 Million in Funding for Cancer Detection Initiatives
Mercy BioAnalytics has successfully closed a $59 million Series B financing round aimed at advancing its early cancer detection programs, marking a significant milestone in oncology diagnostics.
third-news.com
September 3, 2025 at 1:06 PM
Mercy BioAnalytics Secures $59 Million in Funding for Cancer Detection Initiatives#United_States#Waltham#cancer_detection#Ovarian_Cancer#Mercy_BioAnalytics
TOBY Inc. Welcomes Matthew Collier to Board as Independent Director to Drive Healthcare Innovation#USA#Boston#cancer_detection#TOBY_Inc.#Matthew_Collier
TOBY Inc. Welcomes Matthew Collier to Board as Independent Director to Drive Healthcare Innovation
TOBY, Inc. has appointed Matthew Collier as an independent director on its Board. His diverse experience in healthcare innovation will greatly benefit the company.
third-news.com
September 2, 2025 at 3:48 PM
TOBY Inc. Welcomes Matthew Collier to Board as Independent Director to Drive Healthcare Innovation#USA#Boston#cancer_detection#TOBY_Inc.#Matthew_Collier
GRAIL to Showcase Innovation at Morgan Stanley 23rd Annual Healthcare Conference#United_States#Menlo_Park#GRAIL#cancer_detection#Precision_Oncology
GRAIL to Showcase Innovation at Morgan Stanley 23rd Annual Healthcare Conference
GRAIL, Inc. is set to present at the Morgan Stanley Annual Global Healthcare Conference, emphasizing its mission to detect cancer early for effective treatment.
third-news.com
August 26, 2025 at 8:12 PM
GRAIL to Showcase Innovation at Morgan Stanley 23rd Annual Healthcare Conference#United_States#Menlo_Park#GRAIL#cancer_detection#Precision_Oncology
Dr. Forest White Joins Astrin Biosciences to Revolutionize Early Cancer Detection through Proteomics#USA#cancer_detection#St._Paul#Astrin_Biosciences#Dr._Forest_White
Dr. Forest White Joins Astrin Biosciences to Revolutionize Early Cancer Detection through Proteomics
Astrin Biosciences has appointed esteemed MIT researcher Dr. Forest White as Distinguished Scientist to enhance cancer detection methods through proteomics.
third-news.com
August 26, 2025 at 12:06 PM
Dr. Forest White Joins Astrin Biosciences to Revolutionize Early Cancer Detection through Proteomics#USA#cancer_detection#St._Paul#Astrin_Biosciences#Dr._Forest_White
Ultima Genomics' ppmSeq Technology Revolutionizes Whole-Genome MRD Detection with Unprecedented Sensitivity#United_States#Fremont#cancer_detection#Ultima_Genomics#ppmSeq
Ultima Genomics' ppmSeq Technology Revolutionizes Whole-Genome MRD Detection with Unprecedented Sensitivity
Ultima Genomics introduces their ppmSeq technology, showcasing superior sensitivity and efficiency for detecting minimal residual disease (MRD), surpassing existing clinical methods.
third-news.com
August 14, 2025 at 5:52 PM
Ultima Genomics' ppmSeq Technology Revolutionizes Whole-Genome MRD Detection with Unprecedented Sensitivity#United_States#Fremont#cancer_detection#Ultima_Genomics#ppmSeq
GRAIL Reports Impressive Q2 2025 Financial Growth Driven by Galleri Test Sales#United_States#Menlo_Park#GRAIL#cancer_detection#Galleri
GRAIL Reports Impressive Q2 2025 Financial Growth Driven by Galleri Test Sales
GRAIL, Inc. sees a significant 22% revenue growth in Q2 2025, driven by increasing demand for its Galleri cancer detection tests. The CEO expresses optimism for future expansions.
third-news.com
August 12, 2025 at 8:16 PM
GRAIL Reports Impressive Q2 2025 Financial Growth Driven by Galleri Test Sales#United_States#Menlo_Park#GRAIL#cancer_detection#Galleri